Excelsior Sciences develops machine‑ready chemistry (Blocc Chemistry) that automates small‑molecule synthesis and scaling, integrating AI-driven closed‑loop learning to accelerate drug discovery and manufacturing. The platform enables rapid, modular, and iterative production of pharmaceuticals, improving speed, exploration breadth, supply‑chain resilience, and on‑demand scaling.